Stocks › INVA
Innoviva, Inc.
INVA·Nasdaq·
United States·USD
United States·USD$20.83
+0.19 (+0.92%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
INVA
Innoviva, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INVAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of INVA by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 George WhitesidesHouse · D · CA |
INVAInnoviva, Inc. · Stock |
Sale $250,001 - $500,000 |
Apr 23, 2025 | Mar 25, 2025 | Filing ↗ |
| George WhitesidesHouse · D · CA |
INVAInnoviva, Inc. · Stock |
Sale $50,001 - $100,000 |
Apr 23, 2025 | Mar 24, 2025 | Filing ↗ |
Whale Activity
Position changes in INVA reported for 2026-06-30 by 11 tracked institutional filers
- Increased7
- New0
- Held0
- Decreased4
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 11.6M | $262.4M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.2M | $95.8M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 4.0M | $91.7M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.2M | $71.7M | increased |
| MILLENNIUM MANAGEMENT LLC | 2.5M | $57.7M | increased |
| CITADEL ADVISORS LLC | 36.0M | $38.7M | increased |
| Point72 Asset Management, L.P. | 24.1M | $25.9M | increased |
| TWO SIGMA INVESTMENTS, LP | 1.0M | $23.5M | decreased |
| BlackRock, Inc. | 5.2M | $5.5M | increased |
| CITADEL ADVISORS LLC | 185.8K | $4.2M | increased |
| D. E. Shaw & Co., Inc. | 166.3K | $3.8M | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by INVA insiders, by quarter · Form 4
Recent Insider Transactions
262 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Basso StephenChief Financial Officer | Tax withholding | −559 | $22.24 | $12K | May 20, 2026 | Form 4 ↗ |
| Raifeld PavelChief Executive Officer · Director | Tax withholding | −1,130 | $22.24 | $25K | May 20, 2026 | Form 4 ↗ |
| Zhen MarianneChief Accounting Officer | Tax withholding | −1,127 | $22.24 | $25K | May 20, 2026 | Form 4 ↗ |
| Linden JosephineDirector | Grant / award | +9,461 | $0.00 | $0 | May 18, 2026 | Form 4 ↗ |
| Linden JosephineDirector | Grant / award | +5,733 | $0.00 | $0 | May 18, 2026 | Form 4 ↗ |
| Basso StephenChief Financial Officer | Grant / award | +1,123 | $0.00 | $0 | May 15, 2026 | Form 4 ↗ |
| Raifeld PavelChief Executive Officer · Director | Grant / award | +1,123 | $0.00 | $0 | May 15, 2026 | Form 4 ↗ |
| DiPaolo MarkDirector | Grant / award | +9,786 | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Raifeld PavelChief Executive Officer · Director | Grant / award | +126.6K | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Zhen MarianneChief Accounting Officer | Grant / award | +12.8K | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Schlesinger Sarah J.Director | Grant / award | +9,786 | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Basso StephenChief Financial Officer | Grant / award | +38.0K | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Small Derek ADirector | Grant / award | +9,786 | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Haimovitz JulesDirector | Grant / award | +9,786 | $0.00 | $0 | May 4, 2026 | Form 4 ↗ |
| Basso StephenChief Financial Officer | Tax withholding | −1,244 | $23.39 | $29K | Feb 20, 2026 | Form 4 ↗ |
| Raifeld PavelChief Executive Officer · Director | Tax withholding | −2,986 | $23.39 | $70K | Feb 20, 2026 | Form 4 ↗ |
| Zhen MarianneChief Accounting Officer | Tax withholding | −2,460 | $23.39 | $58K | Feb 20, 2026 | Form 4 ↗ |
| Basso StephenChief Financial Officer | Tax withholding | −237 | $21.16 | $5K | Nov 20, 2025 | Form 4 ↗ |
| Zhen MarianneChief Accounting Officer | Tax withholding | −992 | $21.16 | $21K | Nov 20, 2025 | Form 4 ↗ |
| Basso StephenChief Financial Officer | Grant / award | +604 | $0.00 | $0 | Nov 15, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding INVA · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 4.2M | $96.0M | 0.09% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $50.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.9M | $44.1M | 0.05% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.6M | $36.5M | 0.02% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF American Century ETF Trust | 1.4M | $30.8M | 0.11% | May 31, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1.0M | $23.1M | 0.03% | Jun 30, 2026 |
| U.S. SMALL CAP VALUE PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1.0M | $21.1M | 0.11% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 803.3K | $18.2M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 825.8K | $17.3M | 0.05% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 707.3K | $16.1M | 0.11% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list INVA's shares (CUSIP 45781M101), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 3.7M shares5.0%
Jul 31, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Innoviva, Inc. as client
No lobbying filings found naming Innoviva, Inc. as the client.
Government Contracts
Federal awards to Innoviva, Inc. · USAspending
No federal contract awards found for Innoviva, Inc..
U.S. Patents
Recent USPTO applications naming Innoviva, Inc.
No USPTO patent applications found for Innoviva, Inc..
Annual Financials
From INVA's 10-K filings · XBRL
No annual XBRL figures on record for INVA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in INVA's price history.
About Innoviva, Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersBURLINGAME, CA
IncorporatedDE
SEC CIK0001080014 ↗
Former namesTHERAVANCE INC, ADVANCED MEDICINE INC